Impact of polymerase chain reaction testing on Clostridium difficile infection rates in an acute health care facility

American Journal of Infection Control

Volumn 43, Issue 4, 2015, Pages 383-386

  Murad, Yanal M ^a,b   Perez, Justo ^a   Nokhbeh, Reza ^a,b   Ybazeta, Gustavo ^a   Dewar, Brenda ^c   Lefebvre, Sebastien ^a   Diaz Mitoma, Francisco ^a,b  

^a Advanced Medical Research Institute of Canada Vaccine Development and Immunotherapy Research Program   (Canada)

^b NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^c HEALTH SCIENCES NORTH   (Canada)

Author keywords

Clostridium difficile; Outbreak; PCR testing

Indexed keywords

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME IMMUNOASSAY; EPIDEMIC; FECES ANALYSIS; FEMALE; HEALTH CARE FACILITY; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SYSTEM; CLOSTRIDIUM INFECTIONS; COMPARATIVE STUDY; CROSS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HEALTH FACILITIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 84933278122     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2014.12.021     Document Type: Article

References (10)

1. Peterson LR, Mehta MS, Patel PA, Hacek DM, Harazin M, Nagwekar PP, et al. Laboratory testing for Clostridium difficile infection: Light at the end of the tunnel. Am J Clin Pathol 2011;136: 372-80.
2. Grein JD, Ochner M, Hoang H, Jin A, Morgan MA, Murthy AR. Comparison of testing approaches for Clostridium difficile infection at a large community hospital. Clin Microbiol Infect 2014;20: 65-9.
3. PIDAC, Routine practices and additional precautions in all healthcare settings. Annex C: Testing, Surveillance and managment of Clostridium difficile. Ontario, Canada: Provincial Infectious Diseases Advisory Committee; 2013.
4. Litvin M, Reske KA, Mayfield J, McMullen KM, Georgantopoulos P, Copper S, et al. Identification of a pseudo-outbreak of Clostridium difficile infection (CDI) and the effect of repeated testing, sensitivity, and specificity on perceived prevalence of CDI. Infect Control Hosp Epidemiol 2009;30: 1166-71.
5. Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, et al. Differences in outcome according to Clostridium difficile testing method: A prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 2013;13: 936-45.
6. Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C. Approaching zero: Temporal effects of a restrictive antibiotic policy on hospitalacquired Clostridium difficile, extended-spectrum b-lactamase-producing coliforms and methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2013;41: 137-42.
7. Guerrero DM, Carling PC, Jury LA, Ponnada S, Nerandzic MM, Donskey CJ. Beyond the Hawthorne effect: Reduction of Clostridium difficile environmental contamination through active intervention to improve cleaning practices. Infect Control Hosp Epidemiol 2013;34: 524-6.
8. Edmonds SL, Zapka C, Kasper D, Gerber R, McCormack R, Macinga D, et al. Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol 2013;34: 302-5.
9. Simor AE, Williams V, McGeer A, Raboud J, Larios O, Weiss K, et al. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus and of Clostridium difficile infection in Canadian hospitals. Infect Control Hosp Epidemiol 2013; 34: 687-93.
10. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: Admission prevalence and risk factors. Am J Infect Control 2013;41: 390-3.